Dermoplast Post Partum
- Product NDC
- 16864-640
- 11-digit product format
- 168640640
- Labeler code
- 16864
- Product ID
- 16864-640_374dced3-6528-b458-e063-6394a90a911e
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- BENZOCAINE
- Dosage form
- AEROSOL, SPRAY
- Route
- TOPICAL
- Labeler
- Advantice Health, LLC
- Application
- M015
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2025-01-01
- Substance
- BENZOCAINE
- Active strength
- 200 mg/g
- Pharmacologic classes
- Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Dermoplast Post Partum
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BENZOCAINE | 200 mg/g |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | U3RSY48JW5 |
| Rxcui | 211316, 360349 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 16864-640-01 | Dermoplast Post Partum | 78 g in 1 CAN | AEROSOL, SPRAY | 78 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 16864-640-01 | 16864064001 | 78 g in 1 CAN (16864-640-01) | 78 g | 2025-01-01 | No | No | Current |